Literature DB >> 404363

Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: enhanced primary immune response and altered pattern of antibody class elicited.

W E Houston, R J Kremer, C L Crabbs, R O Spertzel.   

Abstract

Complexes of formalinized Venezuelan equine encephalomyelitis (VEE) virus vaccine and specific IgG formed at antigen-antibody equivalence enhanced the immune responses of rhesus monkeys (Macaca mulatta). The predomonant class of antibody elicited by complexes was IgG. In contrast, lower titers of antibody and a more biphasic (IgG-IgM) response were observed after exposure of monkeys to the vaccine alone. In comparison to the response of monkeys primed with antigen, a more rapid secondary response was obtained in monkeys primed with the complexes of antigen and antibody formed at equivalence. A sustained level of protection of 88% was afforded mice 24 hr after immunization with antigen-antibody complexes; development of protection after administration of antigen required eight days to reach this level. Passive protection (80%-100%) was conferred by IgG controls for seven to eight days after immunization. This level of protection was not significantly affected by X-irradiation 24 hr prior to administration of IgG; however, protection in mice similarly irradiated prior to immunization with antigen-antibody complexes was significantly decreased. Early protection afforded by the complexes was not nonspecific (interferon) but was mediated by specific immunologic mechanisms and may be caused by an early formation of IgG.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404363     DOI: 10.1093/infdis/135.4.600

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Colostral immunity in piglets from sows vaccinated with inactivated Aujeszky disease virus vaccine.

Authors:  G Wittmann; J Jakubik
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

Review 2.  Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens.

Authors:  L Jeannine Brady
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

3.  Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.

Authors:  Ussama Abdel-Motal; Shixia Wang; Shan Lu; Kim Wigglesworth; Uri Galili
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Amplification of rabies virus-induced stimulation of human T-cell lines and clones by antigen-specific antibodies.

Authors:  E Celis; T J Wiktor; B Dietzschold; H Koprowski
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

5.  Adjuvant effects of low doses of a nuclease-resistant derivative of polyinosinic acid . polycytidylic acid on antibody responses of monkeys to inactivated Venezuelan equine encephalomyelitis virus vaccine.

Authors:  D G Harrington; C L Crabbs; D E Hilmas; J R Brown; G A Higbee; F E Cole; H B Levy
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

6.  Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.

Authors:  Georgios Tsouchnikas; Juergen Zlatkovic; Johanna Jarmer; Judith Strauß; Oksana Vratskikh; Michael Kundi; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

7.  Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells.

Authors:  Ussama M Abdel-Motal; Heath M Guay; Kim Wigglesworth; Raymond M Welsh; Uri Galili
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

Review 8.  Fcγ receptor pathways during active and passive immunization.

Authors:  Stylianos Bournazos; Jeffrey V Ravetch
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

9.  Multi-therapeutic potential of autoantibodies induced by immune complexes trapped on follicular dendritic cells.

Authors:  Mohey Eldin El Shikh; Maciej Kmieciak; Masoud H Manjili; Andras K Szakal; Costantino Pitzalis; John G Tew
Journal:  Hum Vaccin Immunother       Date:  2013-07-08       Impact factor: 3.452

10.  Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery.

Authors:  Ilaria Pepponi; Elena Stylianou; Craig van Dolleweerd; Gil Reynolds Diogo; Matthew J Paul; Pascal M W Drake; Julian K-C Ma; Rajko Reljic
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.